Maria Sofia Fernandes

Author

i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto ORCID

Also Known As

Fernandes, JR, M FERNANDES, M S Fernandes, M. Sofia Fernandes, M.S. Fernandes, Maria Fernandes, Maria Sofia Fernandes

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto Universidade do Porto Cancer Research UK Imperial College London Endokrinologikum

About

Maria Sofia Fernandes is an author at i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto specializing in cell biology, medicine, and developmental biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	256
2	Cell Biology	3	3	256
3	Endocrinology	2	2	245
4	Public Health	1	1	134
5	Cellular Physiology	1	1	111

Maria Sofia Fernandes

Publications

350

Citations

H-Index

Page 1

	Year	Citations
Regulated expression of putative membrane progestin receptor homologues in human endometrium and gestational tissues Maria Sofia Fernandes, Valerie Pierron, David Michalovich, Journal of Endocrinology Mprs BelongReproductive HealthGynecologyFemale Reproductive SystemFemale Reproductive Function	2005	134
Human Homologs of the Putative G Protein-Coupled Membrane Progestin Receptors (mPRα, β, and γ) Localize to the Endoplasmic Reticulum and Are Not Activated by Progesterone Tom Krietsch, Maria Sofia Fernandes, Jukka Kero, Molecular Endocrinology Cellular PhysiologyProgesterone StimulationSecretory GranulesCell SignalingMolecular Physiology	2006	111
Colorectal cancer-related mutant <i>KRAS</i> alleles function as positive regulators of autophagy Sara Alves, Lisandra Castro, Maria Sofia Fernandes, Oncotarget	2015	59
A machine learning approach for single cell interphase cell cycle staging Hemaxi Narotamo, Maria Sofia Fernandes, Ana Moreira, Scientific Reports	2021	18
S100P is a molecular determinant of E-cadherin function in gastric cancer Patrı́cia Carneiro, Ana Moreira, Joana Figueiredo, Cell Communication and Signaling	2019	17
Specific inhibition of p110α subunit of PI3K: putative therapeutic strategy for<i>KRAS</i>mutant colorectal cancers Maria Sofia Fernandes, Soraia Melo, Sérgia Velho, Oncotarget Crc PatientsPathologyCell DeathCrc CellsCancer Biology	2016	11

Page 1